Mirae Asset Global Investments Co. Ltd. Has $13.94 Million Holdings in Centene Co. (NYSE:CNC)

Mirae Asset Global Investments Co. Ltd. increased its position in shares of Centene Co. (NYSE:CNC - Free Report) by 57.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 187,958 shares of the company's stock after purchasing an additional 68,854 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in Centene were worth $13,941,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. AustralianSuper Pty Ltd raised its holdings in shares of Centene by 23.6% in the fourth quarter. AustralianSuper Pty Ltd now owns 1,215,997 shares of the company's stock worth $90,239,000 after acquiring an additional 231,931 shares during the last quarter. QV Investors Inc. raised its holdings in shares of Centene by 12.3% in the fourth quarter. QV Investors Inc. now owns 305,277 shares of the company's stock worth $22,655,000 after acquiring an additional 33,350 shares during the last quarter. Advisors Preferred LLC acquired a new position in shares of Centene in the fourth quarter worth $2,349,000. Teacher Retirement System of Texas raised its holdings in shares of Centene by 8.2% in the third quarter. Teacher Retirement System of Texas now owns 186,080 shares of the company's stock worth $12,817,000 after acquiring an additional 14,070 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System raised its holdings in shares of Centene by 4.1% in the third quarter. State Board of Administration of Florida Retirement System now owns 677,311 shares of the company's stock worth $46,653,000 after acquiring an additional 26,833 shares during the last quarter. 93.63% of the stock is owned by institutional investors and hedge funds.


Centene Trading Down 0.8 %

CNC stock traded down $0.61 during trading on Thursday, reaching $71.64. 2,171,696 shares of the stock traded hands, compared to its average volume of 3,020,517. The business's 50 day moving average price is $76.89 and its 200-day moving average price is $74.43. Centene Co. has a 52-week low of $60.83 and a 52-week high of $81.42. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.11 and a quick ratio of 1.11. The firm has a market capitalization of $38.32 billion, a PE ratio of 14.59, a P/E/G ratio of 0.91 and a beta of 0.38.

Centene (NYSE:CNC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $0.45 EPS for the quarter, topping analysts' consensus estimates of $0.43 by $0.02. The company had revenue of $39.46 billion for the quarter, compared to analysts' expectations of $36.16 billion. Centene had a return on equity of 14.26% and a net margin of 1.75%. The firm's quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.86 earnings per share. As a group, sell-side analysts forecast that Centene Co. will post 6.75 earnings per share for the current year.

Insiders Place Their Bets

In other Centene news, Director Lori Jean Robinson sold 10,000 shares of the business's stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $77.41, for a total transaction of $774,100.00. Following the transaction, the director now owns 11,455 shares in the company, valued at $886,731.55. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Centene news, Director Lori Jean Robinson sold 10,000 shares of the business's stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $77.41, for a total transaction of $774,100.00. Following the transaction, the director now owns 11,455 shares in the company, valued at $886,731.55. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, President Kenneth J. Fasola sold 12,000 shares of the business's stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $75.07, for a total value of $900,840.00. Following the completion of the transaction, the president now owns 235,365 shares in the company, valued at approximately $17,668,850.55. The disclosure for this sale can be found here. 0.29% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on CNC shares. Barclays started coverage on Centene in a report on Wednesday, March 6th. They issued an "overweight" rating and a $101.00 price target for the company. Stephens reaffirmed an "equal weight" rating and issued a $85.00 price objective (down previously from $92.00) on shares of Centene in a research report on Thursday, March 21st. Wells Fargo & Company lowered their price objective on Centene from $94.00 to $89.00 and set an "overweight" rating for the company in a research report on Monday. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $90.00 price objective on shares of Centene in a research report on Thursday, April 4th. Finally, Truist Financial lifted their price objective on Centene from $83.00 to $86.00 and gave the company a "buy" rating in a research report on Thursday, December 21st. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $85.08.

View Our Latest Stock Report on Centene

Centene Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Further Reading

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Should you invest $1,000 in Centene right now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Featured Articles and Offers

Search Headlines: